Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03249818 · ClinicalTrials.gov registry record · NA
HITT Device Pilot Testing for Traumatic Brain Injury
A NA study, sponsored by Rebiscan.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT03249818 is a NA study that has completed, run by Rebiscan. The registered enrollment target is 7 participants.
The verdict
NCT03249818, a NA study, has completed, sponsored by Rebiscan.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
The purpose of this research study is to collect data from the eyes of traumatic brain injury (TBI) patients. Patients will look at a green target that will measure the fixation of the eye for 30 seconds. In that 30 seconds, the location of the green target will change and the participant is to track, with their eyes, the light as best they can. The device will measure how well fixation was maintained and the speed of the saccadic movements of the eye. Data will then be used to determine whether there is correlation between these measures and known TBI.
Interventions
- DEVICE HITT device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2017-08-22 |
| Est. Completion | 2018-02-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03249818
The ClinicalTrials.gov registry entry for NCT03249818 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rebiscan, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which HITT device is the first listed.
NCT03249818 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03249818 about?
NCT03249818 is a clinical study titled "HITT Device Pilot Testing for Traumatic Brain Injury". The purpose of this research study is to collect data from the eyes of traumatic brain injury (TBI) patients. Patients will look at a green target that will measure the fixation of the eye for 30 seconds. In that 30 seconds, the location of the green target will change and the participant is to trac...
What is the current status of trial NCT03249818?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2017-08-22. Estimated completion is 2018-02-28.
What interventions are being tested in trial NCT03249818?
The interventions under investigation include: HITT device (DEVICE).
Who is sponsoring clinical trial NCT03249818?
This trial is sponsored by Rebiscan, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.